Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
m7-FLIPI identifies patients with early disease progression of FL after therapy
Obinutuzumab (GA101) plus bendamustine as front-line therapy in CLL
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Overview of new combinaton therapies in acute myeloid leukemia (AML)
Naval G. Daver